CIBER
New predictive method for the progression of colorectal cancer
Biomarkers
Cancer
It has been patented a new fetal 'gene signature’ capable to predict the worse evolution of the CRC patients who could suffer a relapse after chemotherapeutic regime or surgery.
2Preclinical Validation,
1R+D
Spain